Email updates

Keep up to date with the latest news and content from BMC Cancer and BioMed Central.

Open Access Highly Accessed Pre-publication history

A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer

Justin M Balko and Esther P Black*

BMC Cancer 2009, 9:145  doi:10.1186/1471-2407-9-145

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 28 Jan 2009
Reviewer's Report Pierre Laurent-Puig 02 Mar 2009
Reviewer's Report Igor Jurisica 12 Mar 2009
Resubmission - Version 2 Manuscript Author's comment 02 Apr 2009
Reviewer's Report Pierre Laurent-Puig 26 Apr 2009
Editorial acceptance 05 May 2009
Published 13 May 2009